SEER Q4 2024 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-5.5% YoY

Gross Profit

$366,0009.3% margin

Operating Income

-$24M-596.1% margin

Net Income

-$22M-550.6% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+0.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$367M

Total Liabilities

$39M

Stockholders' Equity

$328M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-5.5%
Gross Profit	$366,000	$2M	-79.0%
Operating Income	-$24M	-$22M	-5.9%
Net Income	-$22M	-$18M	-22.2%